Physician profile
Michael Lacey
NPI 1700882602
$8,564.28
in general payments reported to CMS, 2019-2025
40 companies · $3,037 in 2025
The $3,037 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $379 · 2021: $465 · 2022: $1,215 · 2023: $1,691 · 2024: $1,547 · 2025: $3,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,292 · Travel and Lodging: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,292.22 |
| Travel and Lodging | $981.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $1,256.72 | 2025 | Renograft, Ardeograft, Surgraft |
| Stryker Corporation | $1,145.48 | 2019-2025 | Augment Injectable, Variax, Hoffmann |
| Treace Medical Concepts, INC. | $1,082.87 | 2022-2025 | |
| Fusion Orthopedics, LLC. | $981.55 | 2023 | |
| Organogenesis INC. | $516.25 | 2021-2023 | Puraply |
| Kerecis Limited | $473.57 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Fusion Orthopedics USA, LLC | $370.60 | 2023-2025 | |
| Linvatec Corporation | $296.34 | 2024-2025 | Biobrace 23mm, Fracture and Correction Colag 2 |
| Nevro Corp. | $181.23 | 2022 | |
| Acera Surgical, INC. | $150.68 | 2022 | |
| Biocomposites INC | $147.63 | 2025 | Stimulan |
| Depuy Synthes Sales INC. | $144.93 | 2020-2025 | Dynacord, Healix Knotless Peek, Fibergraft Aeridyan Matrix |
| Ortho Solutions INC | $143.73 | 2024 | |
| Orthofix Medical, INC. | $132.53 | 2019-2022 | |
| Boston Scientific Corporation | $125.97 | 2025 | Jetstream Sc |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $123.20 | 2025 | |
| Anika Therapeutics, INC. | $116.78 | 2024 | Anchors, Integrity |
| Horizon Therapeutics Plc | $112.94 | 2019-2020 | |
| Medshape, INC. | $111.78 | 2023 | Dynanail |
| Integra Lifesciences Corporation | $110.24 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $89.72 | 2021 | |
| Globus Medical, INC. | $89.71 | 2024 | Harvest |
| Emd Serono, INC. | $86.46 | 2019 | |
| Smith+Nephew, INC. | $76.88 | 2021-2022 | |
| Pacira Therapeutics, INC. | $73.21 | 2019-2020 | |
| Abbott Laboratories | $54.35 | 2022 | |
| Wright Medical Technology, INC. | $45.41 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $42.37 | 2020 | |
| Paragon 28, INC. | $41.84 | 2024-2025 | Precision Mis Bunion |
| Djo, LLC | $40.89 | 2025 | Cmf |
| Acumed LLC | $36.45 | 2023 | Osteomed, Acumed |
| Amgen INC. | $27.15 | 2024 | Krystexxa |
| Triad Life Sciences INC. | $23.35 | 2022 | |
| Bioventus LLC | $22.60 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.13 | 2022 | |
| Ibsa Pharma INC. | $18.00 | 2023 | Tirosint, Licart |
| Paratek Pharmaceuticals, INC. | $17.39 | 2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $16.83 | 2023 | Seglentis |
| Normatec Industries, LP | $11.02 | 2019 | |
| Fidia Pharma USA INC. | $6.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lacey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.